MedTrace Logo

Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer

NCT06673472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1081

Last updated 2024-11-05

No results posted yet for this study

Summary

Patients with lymph node-negative gastric cancer, the prognosis of patients who underwent neoadjuvant therapy was poor than that of those who had upfront surgery.

Conditions

Sponsors & Collaborators

  • Chang-Ming Huang, Prof.

    lead OTHER

Principal Investigators

  • Chang-Ming Huang · Fujian Medical University Union Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-09-04
Completion
2024-09-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06673472 on ClinicalTrials.gov